
Sanara MedTech Investor Relations Material
Latest events

Q1 2025
Sanara MedTech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sanara MedTech Inc
Access all reports
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers sterile negative pressure wound therapy system/drainage devices; hydrocolloid skin protectants; silicone gel sheeting; adhesive silicone gel dressing; medical-grade scar therapy products; antimicrobial barrier film products; surgical liquid adhesives/sealants; antimicrobial dressings and foams; contact layer dressings; gauze impregnated with alginate or other nonadherent gelling agents; hydrogel to provide a moist environment for healing chronic wounds; and topical analgesic sprays.
Key slides for Sanara MedTech Inc


Q2 2024
Sanara MedTech Inc


Q2 2024
Sanara MedTech Inc
Latest articles
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
Ticker symbol
SMTI
Country
🇺🇸 United States